NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children.
Tianyou YangYang WenJiahao LiTianbao TanJiliang YangJing PanChao HuYuxiao YaoJiao ZhangYijuan XinSuhong LiHuimin XiaJing HeYan ZouPublished in: Experimental hematology & oncology (2019)
The data suggest that NRAS and KRAS polymorphisms are irrelevant to hepatoblastoma susceptibility among Chinese population.